Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2014
04/23/2014CN103735920A Medicine for treating hemiplegia and preparation method thereof
04/23/2014CN103735908A Traditional Chinese medicine for treating anxiety
04/23/2014CN103735907A Traditional Chinese medicine for treating facial neuritis
04/23/2014CN103735905A Yening capsule and preparation method thereof
04/23/2014CN103735892A Traditional Chinese medicine formula for treating neurasthenia
04/23/2014CN103735878A Drug for rehabilitation of stroke in recovery phase
04/23/2014CN103735871A Chinese medicinal composition for treating neurasthenia and preparation method thereof
04/23/2014CN103735870A Green herbal medicine band for dizziness and headache
04/23/2014CN103735865A Medicine for preventing and treating exaggerated pain after anesthesia
04/23/2014CN103735856A Dendrobium officinale powder for treating migraine
04/23/2014CN103735839A Traditional Chinese medicine external application agent for treating diabetic foot
04/23/2014CN103735838A Healthcare medicinal liquor capable of nourishing and tonifying kidney and preparation method thereof
04/23/2014CN103735834A Kidney nourishing and root securing pill
04/23/2014CN103735827A Life-extension healthcare wine
04/23/2014CN103735822A Traditional Chinese medicine formula for treating neurasthenia
04/23/2014CN103735808A Traditional Chinese medicinal composition for treating headache due to yin deficiency and yang excess
04/23/2014CN103735805A Health care product and preparation method thereof
04/23/2014CN103735793A Traditional Chinese medicine for treating limb numbness of diabetics after stroke and preparation method thereof
04/23/2014CN103735781A Neurodermatitis treatment agent
04/23/2014CN103735761A Pharmaceutical composition for preventing and treating alzheimer disease and preparation method of pharmaceutical composition
04/23/2014CN103735758A Compound rhizoma typhonii capsule and preparation method thereof
04/23/2014CN103735753A Medicament for treating lumbar disc herniation and lumbar spinal stenosis
04/23/2014CN103735728A New application of cortex lycii alcohol extract, kukoamine A and kukoamine B in neuroprotection
04/23/2014CN103735720A Traditional Chinese medicine ingredient for benefiting Qi and nourishing blood, traditional Chinese medicine composition and preparation method thereof
04/23/2014CN103735714A Application of compound donkey-hide gelatin preparation to preparation of female menstrual health-care medicament
04/23/2014CN103735712A Preparation method of Chinese medicinal composition and Chinese medicinal composition prepared by using preparation method
04/23/2014CN103735691A Drug for treating liver cirrhosis and preparation method thereof
04/23/2014CN103735686A Fragrant plant compound essential oil for relieving depression and achieving physical and mental pleasure and preparation method thereof
04/23/2014CN103735678A Diabetes resistance preparation
04/23/2014CN103735657A Drug for treating insomnia and preparation method thereof
04/23/2014CN103735643A Traditional Chinese medicine composition for treating diabetic peripheral neuropathy
04/23/2014CN103735554A Inhibitors of protein aggregation
04/23/2014CN103735545A Applications of levorotary oxiracetam and oxiracetam in preparing drugs for preventing or treating coma
04/23/2014CN103735527A Oxcarbazepine tablets and preparation method thereof
04/23/2014CN103735500A Tapentadol hydrochloride injection and preparation method thereof
04/23/2014CN103734563A Jelly for eliminating alcohol dependence and preparation method thereof
04/23/2014CN103055069B External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition
04/23/2014CN103028055B Traditional Chinese medicine for treating migraine
04/23/2014CN102993289B Scolopendra mutilans polypeptide toxin kappa-SLPTX-Ssm4a and gene and application thereof
04/23/2014CN102885993B Application of Tibetan medicament composition in preparation of medicament for treating convulsion
04/23/2014CN102836204B Kudzuvine root extracts and preparation thereof
04/23/2014CN102716131B Adenosine A2a receptor antagonist
04/23/2014CN102688362B Medicine composition for treating epilepsy by combined treatment of traditional Chinese medicine and western medicine
04/23/2014CN102603510B Sodium valproate crystal form as well as preparation method and application thereof
04/23/2014CN102503932B Novel gas signal molecule donator and preparation method and use thereof
04/23/2014CN102395577B Diazepinedione derivative
04/23/2014CN102258742B Chinese medicinal medicine composition for treating depression and preparation method thereof
04/23/2014CN102143956B Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
04/23/2014CN102030673B New crystal form of agomelatine and preparation method thereof
04/23/2014CN102018655B Transdermal medicament delivery combined preparation
04/23/2014CN101952280B Bicyclic heterocyclic derivative
04/23/2014CN101861297B Biphenyl carboxylic acids and derivatives thereof
04/23/2014CN101805349B Furan-azo- [3,2-g] chromene compound and application thereof
04/23/2014CN101801406B Tissue kallikrein for the treatment of diseases associated with amyloid protein
04/23/2014CN101687827B Aminodihydrothiazine derivatives substituted with cyclic groups
04/23/2014CN101636145B Long term 24 hour intestinal administration of levodopa/carbidopa
04/23/2014CN101580482B Method for preparing rivastigmine hydrogen tartrate and application thereof
04/23/2014CN101511819B N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
04/23/2014CN101503341B Novel technique for preparing schizandrol A and schizandrol B
04/23/2014CN101328117B 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
04/22/2014US8703773 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/22/2014US8703768 Nitrogen containing heteroaryl compounds
04/22/2014US8703759 Fused heterocyclic compounds as ion channel modulators
04/22/2014US8703752 Use of mifepristone and derivatives therefor as Hedgehog protein signaling pathway modulators and applications of same
04/22/2014US8703746 Compounds as receptor modulators with therapeutic utility
04/22/2014US8703745 Compounds as receptor modulators with therapeutic utility
04/22/2014US8703199 Pharmaceutical compositions of adsorbates of amorphous drug
04/22/2014US8703177 Abuse-resistant mucoadhesive devices for delivery of buprenorphine
04/22/2014US8703141 Method for treating Crohn's disease by administering an anti-IL-12 antibody
04/22/2014US8703096 Beta-amyloid PET imaging agents
04/22/2014CA2752131C Novel derivatives of dihydrobenzoxathiazepines, their preparation process and pharmaceutical compositions containing them
04/22/2014CA2751187C Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
04/22/2014CA2637214C Process for preparing 8-azabicylo[3.2.1]octan-3-one intermediates to 5-ht4 receptor agonist compounds
04/22/2014CA2630595C Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer
04/22/2014CA2629512C Bicyclic cinnamide compound and prophylactic or therapeutic uses thereof
04/22/2014CA2628790C Novel quinolizidine and octahydropyridopyrazine compounds
04/22/2014CA2627623C Methods for inhibiting protein kinases
04/22/2014CA2620418C Benztropine compounds and uses thereof
04/22/2014CA2589489C Method of providing fast relief to a user of a nicotine chewing gum
04/22/2014CA2589192C Phenyl-piperazin methanone derivatives
04/22/2014CA2345209C Antisense modulation of integrin .alpha.4 expression
04/17/2014WO2014059383A1 Gsk3 inhibitors and methods of use thereof
04/17/2014WO2014059363A1 Oral solution formulations of aripiprazole
04/17/2014WO2014059346A1 Methods for the treatment of conditions involving dopamine through administration of piperazine compounds
04/17/2014WO2014059306A1 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
04/17/2014WO2014059295A1 Use of mtor inhibitors to treat vascular cognitive impairment
04/17/2014WO2014059220A1 Glycosphingolipids and methods of use thereof
04/17/2014WO2014059185A1 Amino - dihydrothiazine and amino - dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
04/17/2014WO2014059115A1 Compositions and methods for diagnosis and treatment of neurological disease
04/17/2014WO2014059031A2 Nad biosynthesis and precursors in the prevention and treatment of inflammation
04/17/2014WO2014059029A1 Treatment of age-related and mitochondrial diseases by inhibition of hif-1 alpha function
04/17/2014WO2014058875A2 Combination therapies and uses for treatment of demyelinating disorders
04/17/2014WO2014058742A1 Therapeutic treatment
04/17/2014WO2014058736A1 Neuroactive 19-alkoxy-17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
04/17/2014WO2014058160A1 Composition comprising myricetin as active ingredient for enhancing exercise performance or fatigue recovery
04/17/2014WO2014058071A1 Cyclopropanamine compound and use thereof
04/17/2014WO2014058000A1 Serotonin 2b receptor antagonist
04/17/2014WO2014057997A1 Reprogramming peptide and use thereof
04/17/2014WO2014057995A1 Extract and formulation including extract
04/17/2014WO2014057772A1 Novel pyrazole derivative
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 1833